7-144363309-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005435.4(ARHGEF5):c.640G>A(p.Glu214Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000022 in 1,592,562 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005435.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGEF5 | NM_005435.4 | c.640G>A | p.Glu214Lys | missense_variant | 2/15 | ENST00000056217.10 | NP_005426.2 | |
ARHGEF5 | XM_017012623.3 | c.640G>A | p.Glu214Lys | missense_variant | 2/6 | XP_016868112.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGEF5 | ENST00000056217.10 | c.640G>A | p.Glu214Lys | missense_variant | 2/15 | 1 | NM_005435.4 | ENSP00000056217 | P1 | |
ARHGEF5 | ENST00000498580.5 | c.184+456G>A | intron_variant | 3 | ENSP00000417979 |
Frequencies
GnomAD3 genomes AF: 0.0000335 AC: 5AN: 149306Hom.: 0 Cov.: 26
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248930Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134582
GnomAD4 exome AF: 0.0000208 AC: 30AN: 1443140Hom.: 0 Cov.: 34 AF XY: 0.0000125 AC XY: 9AN XY: 718156
GnomAD4 genome AF: 0.0000335 AC: 5AN: 149422Hom.: 0 Cov.: 26 AF XY: 0.0000274 AC XY: 2AN XY: 73070
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 31, 2023 | The c.640G>A (p.E214K) alteration is located in exon 2 (coding exon 1) of the ARHGEF5 gene. This alteration results from a G to A substitution at nucleotide position 640, causing the glutamic acid (E) at amino acid position 214 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at